SUMMARY A 4 month old child was immunized with a vaccine containing the Sabin live attenuated vaccine strains of all three serotypes of poliovirus. The antigenic and molecular evolution of the Sabin strain of poliovirus type 3 was then followed throughout the entire period of virus excretion. Novel strains appeared at 8, 42 and 52 days post-vaccination and were the products of both intertypic recombination between type 2 and type 3 poliovirus in regions of the genome coding for non-structural proteins and of point mutations in the region coding for the structural proteins. Excretion of virus continued for 73 days. All strains examined reacted with all monoclonal antibodies specific for the main immunodominant antigenic site of type 3 poliovirus, but variation was observed at other, immunorecessive sites. These findings have possible implications for the evolution of the virus in vaccinees or in epidemics and are consistent with the known antigenic stability of the virus.
INTRODUCTION
Poliovirus is a picornavirus of the enterovirus genus. The virion consists of a single strand of messenger-sense RNA enclosed in an icosahedral capsid composed of 60 copies each of the coat proteins VP1, VP2, VP3 and VP4. The sequence of the genomic RNA is known for at least one strain of each of the three serotypes (Toyoda et al., 1984; Kitamura et al., 1981 ; Cann et al., 1984) and the precise structure of the capsid proteins in infectious virus of the type 1 serotype has now been established by X-ray crystallography .
Studies of the molecular basis of such biological properties as the attenuation of neurovirulence of specific virus strains are in progress (Omata et al., 1985; Evans et al., 1985) and antigenically important structural features of the virus have been identified Hogle et al., 1985; P. D. Minor, unpublished results) . However, many details of the biology of the virus and its relationship with its human host remain unexplored in the light of the current detailed understanding of the molecular biology of the virus. Thus vaccines containing one strain of each serotype have proved extremely effective in controlling poliomyelitis, implying that immunization with one virus confers immunity to all strains of the same serotype. This strongly suggests that polioviruses are not able to evade host immunity by antigenic drift of the type observed for influenza virus. The reason for this stability is not known, and it contrasts strongly with the potentially high degree of antigenic variability of poliovirus under immune pressure in vitro .
Similarly, cases of poliomyelitis attributable to reversion to virulence of the live attenuated vaccine strains described by Sabin (Sabin & Boulger, 1973) are rare, suggesting that the attenuated phenotype is very stable in vivo. On the other hand it is known that changes in the molecular and biological character of the virus, leading to an unacceptable degree of virulence arise extremely early in the course of infection by the Sabin type 3 strain .
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Rapid evolution of poliovirus in the wild and during excretion by individuals is also well documented (Kew et al., 1981 ; Nottay et al., 1981 ; Minor, 1980 Minor, , 1982 Yoneyama et al., 1982; Evans et al., 1985) .
We have undertaken a detailed study of the type 3 poliovirus excreted by an infant after first vaccination to follow the evolution of the virus during the entire period of infection as completely as possible, and to attempt to identify the selective pressures exerted on the virus. The rapid increase in virulence of the excreted virus was of particular interest, and has been the subject of a previous paper . This communication describes the subsequent evolution of the virus at both the molecular and antigenic levels.
METHODS
Cell and virus growth. The culture and labelling methods for Hep2c cells and viruses were as described elsewhere (Minor, 1980 (Minor, , 1982 .
Vaccination. The subject was a 4 month old healthy male immunized with 0.1 ml of a trivalent oral poliovaccine (batch number A TRD 278/16) on 20 October 1983. The vaccine had been produced on primary monkey kidney cells.
Faecal samples. Samples were taken from soiled nappies using sterile calcium alginate swab sticks (Inolex). The tip of the swab stick was then broken offinto a 5 ml bottle containing 0.5 ml Hanks' buffered saline, 0.7~ bovine serum albumin and penicillin and streptomycin. Samples were stored at -70 °C until processed.
Isolation of virus. Hep2c ceils were seeded into stoppered test tubes (14 cm x 1 cm diam.) at 107 cells per tube in Eagle's minimal essential medium supplemented with 2 % foetal calf serum and penicillin and streptomycin, and incubated in roller drums at 35 °C for 24 h. The medium was then decanted. A 50 ~tl sample of the faecal suspension was centrifuged for 2 min in an Eppendorf centrifuge to remove solid debris, and then seeded onto the cell layer, allowed to adsorb for 30 min at 35 °C, and then 5 ml of medium was added and the tube incubated at 35 °C. Tubes were examined and frozen when a complete cytopathic effect was observed, Where no cytopathic effect was observed after 5 days, the medium was transferred in toto to a new cell sheet and incubation continued.
Viruses of the different serotypes were isolated from the supernatant fluid using serum mixtures by established methods (D6m6k & Magrath, 1979) and the separated viruses were used to grow pools, which were then checked for purity of serotype. Pools were stored at -70 °C.
T1 RNase oligonucleotide mapping. T1 RNase oligonucleotide mapping of RNA from isolates was carried out as described (Minor, 1980 (Minor, , 1982 .
Primer extension sequencing. Genomic RNA was sequenced by the primer extension dideoxy chain termination method using synthetic oligonucleotide primers as described elsewhere .
Neutralization of isolates by specific monoclonal antibodies. The neutralization of virus by specific monoclonal antibodies was studied as described elsewhere . Twenty ~1 aliquots of a 1 : 10 dilution of antibody as ascitic fluid were mixed with 5 ~tl aliquots of a 1:100 dilution of virus in a 96-well Linbro tray (Flow Laboratories). Dilutions were made in L 15 medium containing 1 ~ foetal calf serum; the plates were sealed with adhesive film and left for 4 h before adding 0.15 ml of a cell suspension containing 5 × 104 Hep2c cells. The plate was then resealed and incubated at 35 °C for 2 days before the cell sheet was stained with naphthalene black. Cell sheets were either totally destroyed or totally preserved under these conditions. Assays were performed at least twice, and included controls of the Sabin type 3 vaccine strain and other type 3 polioviruses.
Antigen blocking tests. The modified single radial diffusion (antigen blocking) test described elsewhere (Ferguson et al., 1984) was used to assess the reaction of antibodies with [35S]methionine-labelled virus preparations.
RESULTS

Time course of virus excretion
The subject (DM) was 4 months old at the time of vaccination with a live attenuated vaccine containing all three poliovirus serotypes. Samples were subsequently taken for several months from all stools produced. This communication deals only with the 211 samples collected during the 110 days between the first and second vaccinations.
Poliovirus of all three serotypes was readily isolated from samples from the 8 days immediately following vaccination. The rapidity with which a cytopathic effect developed after inoculation of the specimen onto a cell sheet implied that large amounts of virus were being excreted. Type 1 poliovirus was no longer detectable in samples subsequent to this initial period, but both type 2 and type 3 poliovirus were isolated from all 124 specimens taken during the 73 day period following vaccination. This excretion period is somewhat longer than normal; 50 of vaccinees excrete virus for only 5 or 6 weeks (Fox et al., 1960) . Virus was more difficult to isolate from samples 53 to 58 (days 29 to 36 post-vaccination) and 100 to 124 (days 67 to 73 postvaccination), where undiluted passage was required to produce a cytopathic effect. This suggested that little virus was present in the specimens from these periods. Sample 125 and several subsequent specimens contained adenovirus 1, and no poliovirus was isolated from any sample later than 124 (day 73). It is therefore possible that an adventitious enteric infection played a part in the ultimate clearance of the poliovirus infection. The type 3 components of the isolated viruses were examined in more detail.
Oligonucleotide mapping of excreted type 3 strains Strains were selected for T1 RNase oligonucleotide mapping from the whole period of infection. Where changes were observed other isolates from the same period were examined to confirm that new strains were appearing, and to establish their time of appearance as accurately as possible. The different strains identified are summarized in Fig. 1 , which shows the oligonucleotide maps of key isolates.
For the first 8 days (samples 1 to 17) the maps of the type 3 strains were indistinguishable from that of the Sabin vaccine strain itself (Fig. 1 a) , although it is known that a significant change in molecular and biological properties had occurred as early as sample 4 . The principal strain excreted for the first 8 days is designated strain 1. Sample 18 gave a map which was clearly a mixture of strain 1 and a minor component, designated strain 2, and by day 9 (sample 20) strain 2 predominated, as shown in Fig. 1 (b). Sample 35 ( Fig. 1 c) gave an apparently pure isolate of strain 2, which differed in at least 13 specific oligonucleotides from strain 1 (arrows in Fig. 1 c) . Repeated isolation from the same faecal specimen produced strains giving the same maps, and strain 2 was observed in all isolates from samples 18 to 65, strongly implying that it was not an artefact of the isolation procedure.
Strain 2 persisted to day 41 (sample 65), but was abruptly replaced by another (strain 3) at day 42 (sample 66) ( Fig. 1 d) . This differed from strain 2 by at least five specific oligonucleotides (arrows in Fig. 1 d) . A further novel strain (strain 4) was isolated between days 52 and 59 (samples 84 and 97). The map is shown in Fig. 1 (e), and differed from that of strain 3 by at least four specific oligonucleotides (arrows in Fig. 1 e) . Strain 3 then re-established itself as the type 3 component until day 73, and the last isolation (sample 124, Fig. l f) .
In addition to these major and reproducible variants, isolates were occasionally obtained which differed from the predominant strain by one or two oligonucleotides, and which were not obtained on re-isolation from the faecal specimens. These variants may have been artefacts of the isolation procedure or could represent subcomponents of the virus population in the specimen.
The nature of the variant strains
The large number of oligonucleotides by which the predominant strains differed from each other and the lack of intermediate strains were difficult to reconcile with the sequential accumulation of point mutations. Kew & Nottay (1984) have reported the occurrence of intertypic recombinants in poliovirus in vivo and this possibility was investigated by a theoretical analysis of the oligonucleotide maps, and by limited sequencing of the various major strains.
The migration rate of an oligonucleotide in a low percentage polyacrylamide gel is governed largely by the ratio of its charge and mass. The pH of electrophoresis in the first dimension is 3.25 and under these conditions the charge is dependent solely on the base composition of the oligonucleotide, such that uracil-rich oligonucleotides migrate most rapidly and cytosine-rich oligonucleotides most slowly. It is possible to assign a relative net charge at pH 3-25 by scoring -1.5 for every cytosine residue, -1.0 for every adenine and + 1.0 for every uracil. The relative migration rates of oligonucleotides in the first dimension can then be predicted from the ratio of net charge to oligonucleotide size. The pH of electrophoresis in the second dimension is 8.6. Under these conditions charge is contributed solely by the phosphate groups of the ribosephosphate backbone, and the net charge is directly proportional to size. The ratio of charge and size is thus constant and the migration rate of an oligonucleotide is determined by its size based on the sieving effect of the high percentage polyacrylamide gels used. Poliovirus evolution during excretion period 697 sample 124, day 73. Arrows indicate altered oligonucleotides, including both additions and deletions, compared to the previous pure strain. * Oligonucleotides are numbered in order from the 5' end, the position of the oligonucleotide being given in accordance with the base numbering of Toyoda et al. (1984) . Map numbers where given identify the oligonucleotide as in Minor (1982) . Mass is measured in terms of oligonucleotide size and charge by assigning -1.5 for every cytosine residue, -1 for every adenine residue, and + 1 for every uracil residue. The enzyme T1 ribonuclease digests RNA at the immediate 3' side of guanosine residues, and it is possible to predict the large fragments which will be generated when an RNA of known sequence is digested to completion. The large T1 RNase-resistant oligonucleotides deduced from the sequence of the Sabin vaccine strain of type 3 poliovirus are given in Table 1 with their location, size and relative net charge at pH 3.25. The fragments are numbered in order from the 5' end of the genome, and their previously assigned map number (Minor, 1982) is given for reference where it is known. Location within the RNA is according to the base numbering of Toyoda et al. (1984) . A map plotted from the data presented in Table 1 is shown in Fig. 2 (b) , and approximated to the experimentally determined map in Fig. 2 (a) . Where oligonucleotides have been excised and sequenced the assignments deduced from the predicted map have proved to be correct D. M. A. Evans, personal communication) . The position of oligonucleotides 44, 45, 47 and 54 is indicated in Fig. 2 (a) and (b) . Fig. 2(d) shows the theoretically Predicted map for a recombinant virus between the Sabin strains of poliovirus type 2 and type 3, having the 5' oligonucleotides of type 3 up to oligonucleotide 45, and the oligonucleotides of type 2 for the remainder of the genome. Modified oligonucleotides are indicated with arrows. Fig. 2 (c) shows the experimentally determined map for the type 3 component of sample 35 (strain 2). The differences between the experimental maps of Fig. 2(a) and (e) were very similar to those observable in the theoretical maps of Fig.  2(b) and (d), and suggested that the type 3 virus designated strain 2 was the product of recombination between the Sabin strains of type 2 and type 3 poliovirus, having the 5" part of the type 3 genome up to oligonucleotide 45 (residue 4840) and the 3' part of the type 2 genome from oligonucleotide 47 (residue 5672).
P. D. MINOR AND OTHERS
Further evidence for this conclusion was provided by limited sequencing of the genome by primer extension at selected positions. The results are summarized in Table 2 . The published sequence of the Sabin strain of type 2 poliovirus differs from that of the Sabin strain of type 3 poliovirus at 38 positions between nucleotides 2770 and 2898, and at 20 positions between nucleotides 4798 and 4923 (Toyoda et al., 1984) . The genome of the type 3 component of sample 35 (strain 2) had the sequence of the type 3 strain at all of these positions. At 91 of 93 positions examined between nucleotides 4949 and 7153, however, the sequence was indistinguishable from that of the published sequence for the type 2 Sabin vaccine strain (Toyoda et al., 1984) . The two aberrant bases were at positions 5538 and 6768 and were found to be the same in our type 2 and type 3 Sabin poliovirus strains. These findings indicated that a recombination event had occurred between nucleotides 4923 and 4949. The location of the recombination could not be identified more closely as the sequences of type 2 and type 3 are identical over this region, which lies in the portion of the genome coding for the non-structural protein P2-X. A similar analysis of the map of strain 3 (samples 66 and 124) ( Fig. 1 d and f) was carried out. Oligonucleotide 44 was present in maps of the RNA of this strain, while oligonucleotides 45 and 47 and most other T1 RNase-resistant fragments from the 3' end of the genome were missing. However, oligonucleotide 54 was present. These observations suggested that the RNA of strain 3 might be a mosaic consisting of the 5' portion of the type 3 genome up to a region between oligonucleotides 44 and 45, the type 2 genome up to a region just before oligonucleotide 54, and the type 3 genome at the remaining 3' sequences. If this were correct, the recombination events generating strain 3 would have occurred at different sites to that generating strain 2.
The nature of the strain 3 genome was confirmed by primer extension sequencing, as shown in Table 2 for the type 3 component of sample 66. The published sequence of the Sabin type 2 poliovirus genome differs from that of the Sabin type 3 poliovirus genome at 38 positions between nucleotides 2770 and 2898, and the type 3 component of sample 66 (strain 3) had the sequence of the type 3 strain at all these positions. Similarly strain 3 had the sequence of type 3 poliovirus at all 15 positions where the two serotypes differed between nucleotides 4636 and 4764. In the partial sequences determined between nucleotides 4789 and 6858, the type 2 and type 3 genomes differ at 68 positions. The sequence of strain 3 was that of the type 2 genome at 66 nucleotides, and that of type 3 at the remaining two (Toyoda et al., 1984) . Our strain of type 3 did not differ from type 2 at these positions, which were at bases 5538 and 6768. From nucleotide 6882 to 7152 the sequence was that of type 3 at all 25 bases where type 2 and type 3 differ, and from nucleotides 7200 to 7330 the sequence was that of type 3 at all 18 bases where the two genomes differ. It was therefore concluded that strain 3 consisted of the type 3 genome from the 5' end to base 4764, the type 2 genome from 4789 to 6858, and the type 3 genome at every base examined to the 3' side of base 6882. The recombination sites could not be defined more accurately because the two genomes did not differ between bases 4764 and 4789 nor between bases 6858 and 6882. The sites, which were different from that generating strain 2, lay in the regions of the genome coding for P2-X and the polymerase proteins. The genomic structure of the virus isolated from sample 124 was the same as that from sample 66, indicating that both viruses were strain 3. This was shown by analysis of the map (Fig. l f) and sequencing (data not shown).
Strain 4 had the same mosaic genomic structure as strain 3 as indicated by its map (Fig. 1 e) and sequencing (data not shown). The differences in the map were therefore presumably due to point mutations.
Antigenic properties of excreted typ~ 3 strains
A previous report (Ferguson et al., 1984) described the isolation of a panel of monoclonal antibodies reacting with type 3 poliovirus which included 2l antibodies reacting with empty capsids only and 32 antibodies able to react with infectious virus. Twenty-six antibodies were able to neutralize infectious virus. The sites recognized by the neutralizing antibodies were located by the isolation and characterization of non-neutralizable mutants Evans et al., 1983) and two sites were identified. Twenty-five of the neutralizing antibodies recognized a strongly dominant site (site 1) in VP1 between amino acids 89 and 100 from the amino terminus, while only one antibody recognized a second subsidiary site (site 2) in VP1 between amino acids 286 and 288.
It has been shown that trypsin treatment of type 3 virus destroys the dominant antigenic site (Fricks et al., 1985) and alters the immunogenic properties of the virus presumably by allowing immunorecessive sites to be detected. Monoclonal antibodies have been raised to trypsintreated Sabin type 3 poliovirus, and it has been shown that site 2 includes components from VP3 and that a third site occurs in VP2 (site 3) (P. D. Minor, unpublished results). We have examined the reaction of all available monoclonal antibodies with the type 3 viruses designated strain 1 (sample 4), strain 2 (sample 35), strain 3 (samples 66 and 124) and strain 4 (sample 84). Reaction was assessed by neutralization or, where the antibodies had no neutralizing activity, by a modified single radial diffusion test in which the reaction of an antibody is demonstrated by its ability to prevent diffusion of the antigen into an agarose gel (Ferguson et al., 1984) . The results are summarized in Table 3 .
All strains examined were neutralized by all antibodies specific for the immunodominant site 1. However, variation was observed at other sites. One antibody specific for the immunorecessive site 2 failed to neutralize strain 3. Site 2 included residues 58 to 60 and 77 to 79 of VP3 and residues 286 to 290 of VP1. Three of four antibodies specific for the immunorecessive site 3 failed to react with strains 2, 3 or 4. Site 3 was located in VP2 in the region of residues 164, 166, 167 and 171. Similarly 17 of the antibodies reacting only with empty capsids reacted with strain 3, 20 reacted with strains 2 and 4, while all 21 reacted with strain 1.
The sequences of the genomic RNA of two isolates of strain 3 samples 66 and 124, were determined in the vicinity of the regions coding for sites 1, 2 and 3. Substitutions were found in the regions coding for VP3 at residue 77 (site 2), which was an aspartic acid in the Sabin type 3 strain and an asparagine in strain 3, and in the regions coding for VP2 at residue 165 (site 3) where the amino acid was an alanine in the Sabin type 3 strain and a threonine in strain 3. At all other positions examined, the sequence corresponded to that of the Sabin type 3 strain. The sequence of the genomic RNA of strain 2 (sample 35) and strain 4 (sample 84) were also determined in the vicinity of the regions coding for antigenic sites 1, 2 and 3, and both had a substitution in VP2 at position 165 (site 3) which was an alanine in the parental Sabin strain and a threonine in the variant strains. At all other positions examined the sequence was that of the Sabin type 3 vaccine strain. At all positions in the portion of the genome coding for the structural proteins of strain 1 (sample 4), the sequence was that of the Sabin type 3 vaccine strain .
DISCUSSION
The successful control of poliomyelitis by the use of the live attenuated vaccines developed by Sabin implies that the strains have a stable attenuated phenotype, and that poliovirus strains in general are antigenically very similar and not subject to antigenic drift. In a previous communication it was reported that a primary vaccinee (DM) excreted a type 3 virus of unacceptable ncurovirulence for animals within 48 h of vaccination, and this was attributed to a single base change in the genome at nucleotide 472 from the 5' terminus, in a region with no known coding function. The same change was observed in other vaccinees on the same time scale, and the observation implied that the vaccine strain was genetically and phenotypically surprisingly unstable.
The data reported here extend the studies of isolates of type 3 poliovirus from the same vaccinee throughout the entire period of virus excretion following the first vaccination, and demonstrate that the virus continued to evolve rapidly. Four distinct strains of type 3 poliovirus have been shown to be excreted during the 73 day period following vaccination, novel strains arising at day 8 (strain 2), day 42 (strain 3) and day 52 (strain 4) while strain 3 re-emerged at day 59, when virus excretion was beginning to diminish as indicated by difficulties in isolating virus.
The time at which the novel strains emerged may be significant. Thus excretion of type 1 virus ceased at day 8 at the same time that strain 2 became dominant over strain 1. Crainic et al. (1983) and Kew & Nottay (1984) have reported that the character of the type l component excreted by recipients of Sabin vaccine may change at 8 to 10 days post-infection, in both antigenic and molecular characteristics. It is thus likely that a host response at about this time exerts a selective pressure upon the virus which either clears the infection, as for the type 1 component of the samples studied here, or selects novel strains, as for the type 3 component of the samples studied here and the type 1 components referred to by Crainic et al. (1983) and Kew & Nottay (1984) . Similarly, in 50~ of vaccinees an infection with the Sabin vaccine strain lasts only 5 to 6 weeks (Fox et al., 1960) . In the case of DM, however, excretion persisted for 10-5 weeks, after a novel strain emerged at 6 weeks. This may also suggest a host response at this period. In view of the fact that the strains excreted after 8 days and after 6 weeks were antigenically different from the preceding strains, it is reasonable to postulate that the selection of novel strains included the effects of a specific immune response by the host. Strain 4, however, had the antigenic characteristics of strain 2.
The nature of the novel strains was surprising in that they appear to have been generated largely by recombination between the type 2 and type 3 Sabin vaccine strains. Comparable findings in vitro are well documented for foot-and-mouth disease virus, another picornavirus (King et al., 1982) and also for poliovirus (Kew & Nottay, 1984) . Recombination may be assumed to occur only when a single cell is infected by both serotypes. Its occurrence in DM thus implies a high multiplicity of infection in the human gut. However, all of the recombination sites, of which there was one to generate strain 2 and two different sites to generate strain 3, were located in the part of the genome coding for the non-structural proteins P2-X or polymerase. Thus none of the recombination events could affect antigenicity directly, and antigenic variants were apparently generated by single point mutations in regions known to code for antigenically significant sites P. D. Minor, unpublished results) . It is not clear why recombinant viruses containing point mutations affecting antigenicity should have a selective advantage over non-recombinant viruses with similar mutations if the only selective pressure on the virus is a host immune response. Kew & Nottay (1984) reported recombination in the P2-X region for intertypic recombinants between type 1 and type 2 or type 2 and type 3 similar to that reported here. While the regions concerned in the generation of the DM recombinants were of high homology, there were differences between the two genomes, allowing the three sites to be identified to within 26, 25 and 24 bases.
It is notable that strain 2 was the only type 3 strain isolable from days 9 to 42, and lacked the 3' terminal section of the type 3 genome. Strain 3, however, emerged at day 42 and had regained this portion of the type 3 genome. This implies either that another strain containing the Y portion of the type 3 genome was present during the period of excretion of strain 2, or that the vaccinee was re-infected with type 3 virus, which is considered unlikely.
The most striking antigenic feature of the excreted virus was the complete invariance of the site which has been shown to be a major target of neutralizing antibodies. Monoclonal antibodies with neutralizing activity have been prepared using animals immunized with wild and Sabin-related strains of type 3 poliovirus (Ferguson et al., 1984) . Of the 26 isolated, 25 were against a single site which is therefore apparently the most potent immunogenic locus on the virus. The immunodominant site can be destroyed by trypsin treatment of the virus (Fricks et al., 1985; Hogle et al., 1985 ; J. P. Icenogle, unpublished results) and the resulting virus is less potent as an immunogen, although it retains full infectivity. Monoclonal antibodies raised to such treated virus react with subsidiary sites in VP1, VP2 and VP3 (P. D. Minor, unpublished results) and in contrast to the immun0dominant site these subsidiary sites were subject to variation in the DM strain. Other strains are under investigation to examine the generality of this observation. It was of interest that the recognition of the DM strains by three non-neutralizing monoclonal antibodies specific for empty capsids (C antigen) paralleled the reaction of the strains with one of the antibodies recognizing the VP3 site. It is therefore conceivable that these antibodies recognize the same regions of VP3 in a different conformation. This possibility is under investigation.
The studies reported here concern a single child, and it is possible that they are atypical. If they prove to be generally true, however, they have implications for the stability of both the Sabin vaccine strain of poliovirus and wild strains.
The principal antigenic site is as readily mutated in vitro as the subsidiary sites, and the mutants obtained are of similar stability. It is therefore likely that stability of the main site compared to the subsidiary site reflects a lack of immune pressure rather than the need for a particular sequence at the main site for virus viability. The implications of this conclusion are under active investigation.
